Blue Cross prices the AI coding boom at $942 million, days after Abridge moved into billing
BCBSA says AI-assisted coding added $942 million over two years with no sign patients got sicker. Ten days earlier, Abridge, the $5.3 billion scribe leader, shipped a tool that vets claims before hospitals submit them.
Vincent Jiang · 3 min read
The payer finally put a number on the bot war
The Blue Cross Blue Shield Association has priced the hospital AI billing fight: an estimated $942 million in added spending across its plans from early 2023 through late 2025, with the share of inpatient stays billed as medically complex rising from 37% to 40% 1. Its reading of its own data is blunt: no evidence of any corresponding change in the care delivered 12.
Luke Chalker, the association's senior vice president of product and data science, rejects the war framing. "It's not a war. It's a completely one-sided blood bath," he said, with insurers on the losing side 2.
More codes, no more care
About 70% of the lift came from 55,000-plus excess complex cases, and $653 million of it from secondary diagnoses, conditions like anemia and low sodium that surface on routine lab reports and pushed stays into higher-severity, higher-reimbursement diagnosis-related groups 13.
$653 million of the $942 million came from secondary diagnoses, not from sicker patients
- Estimate
Data
| Value | |
|---|---|
| Secondary diagnoses in added spending ($M) | 653 |
| Excess complex cases, 55,000-plus ($M) | 289 |
| Top-quartile excess anemia coding, 55,000 cases basis ($M) (estimate) | 30.4 |
The sharpest exhibit is an inversion. Hospitals in the top quartile for coding posthemorrhagic anemia diagnosed it in 13.7% of major bowel cases versus 9.9% elsewhere, and transfused those patients less often, 16.9% against 19.3% 13. More documented sickness, less treatment.
The hospitals that code the most anemia transfuse the least
- Top quartile by coding rate
- Other hospitals
Data
| Top quartile by coding rate | Other hospitals | |
|---|---|---|
| Anemia coded in stay | 13.7% | 9.9% |
| Transfused if diagnosed | 16.9% | 19.3% |
Both camps swear they are losing
Hospital finance chiefs tell it from the other trench. "All the insurers are using AI to scan our charts to look for claims to deny. For the same reason, we're looking at the same charts today," McLaren Health Care CFO Dave Mazurkiewicz said 4.
HCA's finance chief says hospitals run "behind the payers," and New York City's public hospital system calls it a "rock 'em, sock 'em robot" fight in which "nobody's going to win" 3. The feud is old, the weapons are new, and congressional committees are hammering both sides over spiraling costs 5.
The supply side sells the record being audited
BCBSA named no vendor. The closest thing to a face on the provider side is Abridge: $830 million raised at a $5.3 billion valuation, an ambient scribe deployed across more than 300 health systems and projected to log 100 million-plus clinician conversations this year, plus a $775.72 million VA ceiling that pays only as task orders land 67.
On 14 September it launched pre-bill review, which checks a claim's coded diagnoses and diagnosis-related groups against what the documentation supports before the claim goes out the door 8. "Health systems aren't reimbursed for the care that they deliver. They're reimbursed for the care they document that they delivered," CEO Dr. Shiv Rao said at launch 8. Days after the Blue Cross number landed he conceded the endpoint could be "bots fighting bots, agents fighting agents," a "horrible dystopic future nobody wants to live in," then argued a shared record could still cut costs 2.
The payer camp is already in the building. Aetna Chief Medical Officer Ben Kornitzer, who has called AI's early impact on healthcare "largely inflationary" 3, sat on Abridge's June keynote panel on connecting documentation and reimbursement 9.
Audits for hospitals, premiums for everyone else
BCBSA concedes it read claims, not charts, and more analyses are coming, starting with outpatient care, where its March maternity study already projected at least $1.67 billion in exposure 13. Chalker says the trend "hasn't stopped" 3.
Employers are budgeting the pass-through already: benefit costs up 8% per employee next year and plan costs up 11%, with AI software among the named drivers 4. The tell on whether hospitals can police their own coding is whether pre-bill review spreads faster than payer audits. The audits will land on hospitals. The premiums land on everyone else.
How this brief was made
01Gathered & sourced283 channels · 1,419 articles▾
Agents swept 283 channels and ingested 1,419 articles, then de-duplicated and ranked them for signal.
02Verified & cross-validated9 claims · 23 data feeds▾
Every one of 9 load-bearing claims was checked against primary sources, with 23 live data feeds reconciling the figures and charts.
- 1Fierce Healthcare, Hospitals' use of AI coding tools cost BCBSA plans $942M more for similar care: analysis, 24 September 2026
- 2TechCrunch, Insurers claim AI is already increasing healthcare costs, 26 September 2026
- 3Becker's Hospital Review, Hospitals say they're losing the AI billing war. A new BCBS study suggests otherwise, 24 September 2026
- 4Inc., It's a 'Horrible Dystopic Future.' Hospitals and Insurers Are Fighting a Nearly $1 Billion Bot War, 25 September 2026
- 5The New York Times, Battle of Hospital A.I. vs. Insurer A.I. Is Pushing Medical Costs Higher, 24 September 2026
- 6Forbes, Abridge company overview and funding history, updated 16 April 2026
- 7HIT Consultant, Abridge Wins Seat on $775.7M VA Enterprise Contract to Power Ambient Clinical AI, 22 September 2026
- 8Fierce Healthcare, Abridge expands into revenue cycle with AI-powered pre-bill claim review, 14 September 2026
- 9Abridge, Abridge Keynote 2026: patient-centered clinician intelligence platform, 11 June 2026
03Reviewed & edited2 human editors▾
2 editors read the draft against the evidence, tuned the framing, and signed off before it shipped.
Become a contributor
Reporting on the business of AI and want it read? We take pitches from outside contributors who bring primary sources and a number worth arguing about.
Deepdive
AI-generated from this story and its cited sources. Not investment advice.



